Drugs / human regular insulin
human regular insulin
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial · 1 missed | ||||||
| Phase 1 | NCT00370643 | Oct 2002 → Nov 2004 | cardiac ventricle disorder, heart valve disorder, hyperglycemia | University of Sao Paulo | Completed | Missed primary |
| Phase 21 trial | ||||||
| Phase 2 | NCT00592410 | Feb 2007 → Nov 2008 | acute kidney injury | Vanderbilt University | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 42 trials | ||||||
| Phase 4 | NCT02746432 | Jan 2018 → Mar 2021 | colon carcinoma | King Saud University | Unknown | No outcome recorded |
| Phase 4 | NCT04237493 | Feb → Jul 2017 | type 2 diabetes mellitus | University of Jordan | Completed | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 1 | NCT00513643 Comparator | Apr → Jun 2002 | diabetes mellitus | Profil Institute for Metabolic Research GmbH | Completed | No outcome recorded |
| Phase 3 | NCT01136746 Comparator | Mar → Nov 2011 | hyperglycemia | Eli Lilly and Company | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT00000620 Background | Sep 1999 → Jun 2009 | atherosclerosis, coronary artery disorder, hyperlipoproteinemia, hypertensive disorder +1 | National Heart, Lung, and Blood Institute (NHLBI) | Completed | Missed primary |
| Phase 4 | NCT04690309 Comparator | Jul 2018 → Dec 2020 | type 5 diabetes mellitus | Polish Society of Diabetology | Unknown | No outcome recorded |
| Phase 4 | NCT00859079 Comparator | Jun → Dec 2006 | hyperglycemia, type 2 diabetes mellitus | Medical University of Graz | Completed | No outcome recorded |
| Phase 4 | NCT00747409 Comparator | Jul 2004 → Mar 2009 | type 2 diabetes mellitus | Munich Municipal Hospital | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human regular insulin | “2 U/kg bolus of insulin (Human regular insulin) to be administered IV followed by an infusion of 2 U/ kg/min.” NCT02746432 ↗9“Treatment with human regular insulin administered subcutaneously before breakfast, lunch and supper” NCT04690309 ↗ “human regular insulin (Novolin ge Toronto)” NCT00000620 ↗ |
| Known as | human regular insulin (Novolin ge Toronto) | “human regular insulin (Novolin ge Toronto)” NCT00000620 ↗ |
| Known as | human regular insulin (Novolin R) | “human regular insulin (Novolin R)” NCT00000620 ↗ |
| Known as | insulin | “2 U/kg bolus of insulin (Human regular insulin) to be administered IV followed by an infusion of 2 U/ kg/min.” NCT02746432 ↗ |
| Modality | Protein / enzyme biologic | “human insulin (HI)” PMID 26772807 ↗ Jan 2016 |
| Route | Intravenous | “continuous intravenous insulin” PMID 9033300 ↗ Feb 1997 |